Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- Check6 days agoChange DetectedTaoyuan District, Taiwan was removed and Taoyuan, Taiwan was added in the study's Taiwan locations list.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check85 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no user-visible changes to study details, eligibility criteria, locations, or timelines.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no substantive changes to trial details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.